Author(s)

Andreas Nitsch¹, Matthias Bernhard Stope²

¹Department of Trauma, Reconstructive Surgery and Rehabilitation Medicine, University Medicine Greifswald, Greifswald, Germany.
²Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.

Renal cell carcinoma (RCC) is one of the most important urological tumors and is one of the most common cancer diseases worldwide. Unfortunately, the treatment options are very limited due to resistances. Non-invasive physical plasma (NIPP) is currently becoming a promising and very well tolerated treatment option for cancer. NIPP represents a highly energized gas and induces varying antioncogenic cell responses in tumor cells. And also in the case of RCC, NIPP treatment has great potential to enhance and supplement existing anticancer treatment options. Outstanding characteristics of NIPP treatment are 1) a precise and local effect on the treated tissue and 2) an almost exclusive effect on treated tumor cells without side effects. This allows an enormously large therapeutic window and makes the combination of NIPP treatment and classical therapy appear particularly promising. In addition to RCC, plasma oncology offers an extremely innovative physical treatment method for future oncology in general. This brief review article summarizes the current knowledge on the potential use of NIPP in RCC therapy.

Physical Plasma, Non-Invasive Physical Plasma, Cold Plasma, Plasma Medicine, Plasma Oncology, Renal Cell Carcinoma

Nitsch, A. and Stope, M. (2021) The Future Therapy of Renal Cell Carcinoma? Non-Invasive Physical Plasma as an Innovative Oncological Therapy Modality. Journal of Cancer Therapy, 12, 602-610. doi: 10.4236/jct.2021.1211052.